dr. locke on the zuma-i trial of kte-c19
Published 7 years ago • 251 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:08
dr. locke on the zuma-6 trial of axi-cel with atezolizumab for dlbcl
-
1:57
dr. frederick locke on kte-c19 for refractory nhl
-
1:16
dr. neelapu on zuma-1 trial design of kte-c19
-
2:56
a look at zuma-2 trial
-
0:55
frederick l. locke, md, discusses the results of the zuma-1 pivotal phase 2 study with kte-c19
-
13:07
what is a locum doctor? | locuming explained
-
6:37
ksqa: dr. ralph nixon
-
1:05:15
obesity - endocrine - copm weekly24
-
1:50
dr. locke discusses long-term follow-up of zuma-1 trial for nhl
-
1:18
dr. neelapu on the safety profile of kte-c19 in patients with lymphoma
-
0:53
dr. neelapu on next steps with kte-c19 in lymphoma
-
1:01
frederick locke, md, explains the zuma-1 results and what it means to dlbcl patients
-
3:49
frederick locke on axi-cel and zuma-7
-
2:22
frederick locke, md, summarizes outcomes from the zuma-1 clinical trial presented at ash 2020
-
1:34
dr. neelapu on interim results of the phase ii zuma-1 study in dlbcl
-
3:41
interim results from the zuma-1 trial of novel car-t cells against non-hodgkin lymphoma
-
1:02
investigating lava-051 in r/r myeloma and cll: pharmacodynamic and early clinical cata
-
8:01
high-risk lymphoma: the zuma-1 and scholar-1 trials
-
1:13
dr. neelapu on primary results of the zuma-1 trial in nhl
-
2:24
dr. neelapu on axi-cel in the zuma-1 trial for refractory aggressive non-hodgkin lymphoma
-
0:58
dr. karmali on fda approval of kte-c19 in non-hodgkin lymphoma
-
3:17
frederick locke, md, discusses details from the zuma-9 clinical study presented at ash 2020